The metabolic enzyme ethanolamine-phosphate phosphorylase (ETNPPL) was found to inhibit autophagic flux-mediated PA-induced insulin resistance in hepatocytes via the ARG2/ROS signaling cascade, suggesting that targeting ETNPPL may be a potential approach for the treatment of T2DM (90). Here, ETNPPL is linked to Insulin resistance.